FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/02/011740 [Registered on: 07/02/2018] Trial Registered Prospectively
Last Modified On: 07/02/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to compare the effects of stopping phototherapy administered for newborn babies affected by jaundice at low and high serum bilirubin levels. 
Scientific Title of Study   A comparison of two targets of serum bilirubin concentration for phototherapy discontinuation in neonatal jaundice. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Veda Senthil Velan Ganesan 
Designation  Postgraduate 
Affiliation  PSG Institute of Medical Sciences and Research 
Address  Department of Paediatrics, PSG Institute of Medical Sciences and Research, Peelamedu, Coimbatore

Coimbatore
TAMIL NADU
641004
India 
Phone  8939462670  
Fax    
Email  doctorvsv@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Ramesh S 
Designation  Associate professor 
Affiliation  PSG Institute of Medical Sciences and Research 
Address  Department of Paediatrics, PSG Institute of Medical Sciences and Research, Peelamedu, Coimbatore

Coimbatore
TAMIL NADU
641004
India 
Phone  9962823975  
Fax    
Email  drsramesh95@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ramesh S 
Designation  Associate professor 
Affiliation  PSG Institute of Medical Sciences and Research 
Address  Department of Paediatrics, PSG Institute of Medical Sciences and Research, Peelamedu, Coimbatore

Coimbatore
TAMIL NADU
641004
India 
Phone  9962823975  
Fax    
Email  drsramesh95@gmail.com  
 
Source of Monetary or Material Support  
Veda Senthil Velan Ganesan, Postgraduate, Department of Paediatrics, PSG Institute of Medical Sciences and Research, Peelamedu, Coimbatore. 641004 
 
Primary Sponsor  
Name  Veda Senthil Velan Ganesan 
Address  Postgraduate Department of Paediatrics, PSG Institute of Medical Sciences and Research, Peelamedu, Coimbatore 
Type of Sponsor  Other [Principal investigator] 
 
Details of Secondary Sponsor  
Name  Address 
Ramesh S  Associate Professor, Department of Paediatrics, PSG Institute of Medical Sciences and Research, Peelamedu, Coimbatore. 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Veda Senthil Velan Ganesan  PSG Institute of Medical Sciences and Research  Neonatal Unit, Department of Paediatrics.
Coimbatore
TAMIL NADU 
8939462670

doctorvsv@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Neonatal jaundice,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A  Phototherapy will be stopped once serum bilirubin falls 1.0 to 2.9mg/dl below treatment threshold. 
Comparator Agent  Group B  Phototherapy will be stopped once serum bilirubin falls 3.0 mg/dl below treatment threshold 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  7.00 Day(s)
Gender  Both 
Details  1)Babies with gestational age ≥35 weeks,
2)Babies with birth weight >1800 grams,
3)Babies requiring phototherapy for the first time,
4)Babies with onset of jaundice ≤7 days. 
 
ExclusionCriteria 
Details  Babies planned for immediate exchange transfusion at the time of admission 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Number of babies who require re-initiation of phototherapy.  24 hours after stopping phototherapy 
 
Secondary Outcome  
Outcome  TimePoints 
Total duration of phototherapy including treatment after rebound hyperbilirubinemia and total duration of hospital stay.  Less than 7 days 
 
Target Sample Size   Total Sample Size="240"
Sample Size from India="240" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/02/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="7"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a randomized, open labelled, parallel group, single centre study comparing the occurance of significant rebound jaundice when phototherapy was stopped in two targets below the treatment threshold in babies with neonatal jaundice. Secondary outcomes will be compared are total duration of phototherapy and total duration of hospital stay in two groups. 
Close